Company Overview

IVAX Pharmaceuticals UK, IVAX Corporation's largest European subsidiary, is engaged in the research, development, manufacturing and marketing of branded and brand equivalent (generic) pharmaceuticals. Our aim is to provide high-quality pharmaceuticals that improve the health of our customers. Our Company has achieved spectacular growth since 1990 to become a top 10 UK pharmaceutical company. We market and are developing a variety of asthma drugs in aerosol and non-aerosol dry-powder formulations.

The Company also markets Steri-Neb® formulations for use in nebulizers to treat asthma and chronic obstructive pulmonary disease. A leading supplier of generic medicines, with over 300 product lines, IVAX Pharmaceuticals UK is the UK industry leader in first-to-market generic alternatives and our new product availability is second to none. Headquartered at London's Royal Docks, IVAX Pharmaceuticals UK has a state-of-the art manufacturing and distribution facility at Runcorn, Cheshire and at Waterford, Ireland.

Product Portfolio
Products that make a difference. IVAX is engaged in the research, development, manufacturing and marketing of branded and brand equivalent (generic) pharmaceuticals.

Asthma
IVAX markets a variety of asthma drugs in aerosol (both CFC and HFA) formulation. We also market Steri-Neb® formulations of ipratropium bromide and salbutamol for use in nebulizers to treat asthma and chronic obstructive pulmonary disease.

Generics
IVAX is a leading UK manufacturer and supplier of generic medicines to the NHS with over 300 product lines and the UK industry leader in first-to-market generic alternatives with new product availability second to none.

Alternative Brands
IVAX supplies cost-effective alternatives to expensive brands where no generic product exists.